MTS1/MTS2 (p15/p16) deletions and p53 mutations in mantle cell (centrocytic) lymphoma

被引：0
|
作者：
Williams, ME
Woytowitz, D
Finkelstein, SD
Swerdlow, SH
机构：
[1] UNIV VIRGINIA,SCH MED,CHARLOTTESVILLE,VA 22908
[2] UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2975 / 2975
页数：1
相关论文
共 50 条
  • [21] Mutations of CDKN2 (MTS1/p16(INK4A)) and MTS2/p15(INK4B) genes in human stomach, hepatocellular, and cholangio-carcinomas
    Jae-Ryong Kim
    Seong-Yong Kim
    Bong-Hwan Lee
    Sang-Woon Kim
    Hong-Jin Kim
    Jung-Hye Kim
    Experimental & Molecular Medicine, 1997, 29 : 151 - 156
  • [22] Incidence and clinical significance of CDKN2/MTS1/p16(ink4A) and MTS2/p15(ink4B) gene deletions in childhood acute lymphoblastic leukemia
    Zhou, MX
    Gu, LB
    Yeager, AM
    Findley, HW
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1997, 14 (02) : 141 - 150
  • [23] Mutations/deletions in the p16/MTS1 gene in primary oral SCC & cell lines.
    Elamin, F
    Steingrimsdottir, H
    Penhallow, J
    Sartor, M
    Warnakulasuriya, S
    Prime, S
    Johnson, NW
    JOURNAL OF DENTAL RESEARCH, 1996, 75 (05) : 1136 - 1136
  • [24] FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA
    CALDAS, C
    HAHN, SA
    DACOSTA, LT
    REDSTON, MS
    SCHUTTE, M
    SEYMOUR, AB
    WEINSTEIN, CL
    HRUBAN, RH
    YEO, CJ
    KERN, SE
    NATURE GENETICS, 1994, 8 (01) : 27 - 32
  • [25] Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
    EE Schmidt
    K Ichimura
    KR Messerle
    HM Goike
    VP Collins
    British Journal of Cancer, 1997, 75 : 2 - 8
  • [26] Alterations in the tumor suppressor genesp53, RB, p16/MTS1, andp15/MTS2 in human pancreatic cancer and hepatoma cell lines
    Miyuki Kaino
    Journal of Gastroenterology, 1997, 32 : 40 - 46
  • [27] Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
    Schmidt, EE
    Ichimura, K
    Messerle, KR
    Goike, HM
    Collins, VP
    BRITISH JOURNAL OF CANCER, 1997, 75 (01) : 2 - 8
  • [28] Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer
    Kudoh, K
    Ichikawa, Y
    Yoshida, S
    Hirai, M
    Kikuchi, Y
    Nagata, I
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (04) : 579 - 582
  • [29] Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16(INK4A)/CDKN2, MTS2/p15(INK4B), p53, and Rb genes in primary lymphoid malignancies
    Hangaishi, A
    Ogawa, S
    Imamura, N
    Miyawaki, S
    Miura, Y
    Uike, N
    Shimazaki, C
    Emi, N
    Takeyama, K
    Hirosawa, S
    Kamada, N
    Kobayashi, Y
    Takemoto, Y
    Kitani, T
    Toyama, K
    Ohtake, S
    Yazaki, Y
    Ueda, R
    Hirai, H
    BLOOD, 1996, 87 (12) : 4949 - 4958
  • [30] Deletion of P15 (MTS2) in head and neck squamous cell carcinomas
    Roesler, JM
    Livingston, EH
    Srivatsan, E
    Chang, P
    Wang, MB
    JOURNAL OF SURGICAL RESEARCH, 1998, 77 (01) : 50 - 54
12345